Alprenolol: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
<StructureSection load='' size='340' side='right' caption=' | <StructureSection load='' size='340' side='right' caption='Alprenolol' scene='10/1011229/Cv/1'> | ||
Alprenolol, or alfeprol, alpheprol, and alprenololum (Gubernal, Regletin, Yobir, Apllobal, Aptine, Aptol Duriles), is a non-selective beta blocker as well as a 5-HT1A and 5-HT1B receptor antagonist,<ref name="a1">PMID:809360</ref> used in the treatment of angina pectoris.<ref name="a2">PMID:4393977</ref> See also [https://en.wikipedia.org/wiki/Alprenolol Alprenolol], [[Adrenergic receptor]], and [[5-hydroxytryptamine receptor]]. | Alprenolol, or alfeprol, alpheprol, and alprenololum (Gubernal, Regletin, Yobir, Apllobal, Aptine, Aptol Duriles), is a non-selective beta blocker as well as a 5-HT1A and 5-HT1B receptor antagonist,<ref name="a1">PMID:809360</ref> used in the treatment of angina pectoris.<ref name="a2">PMID:4393977</ref> See also [https://en.wikipedia.org/wiki/Alprenolol Alprenolol], [[Adrenergic receptor]], and [[5-hydroxytryptamine receptor]]. | ||
Latest revision as of 14:28, 21 January 2024
Alprenolol, or alfeprol, alpheprol, and alprenololum (Gubernal, Regletin, Yobir, Apllobal, Aptine, Aptol Duriles), is a non-selective beta blocker as well as a 5-HT1A and 5-HT1B receptor antagonist,[1] used in the treatment of angina pectoris.[2] See also Alprenolol, Adrenergic receptor, and 5-hydroxytryptamine receptor. (3nya). . |
| ||||||||||
ReferencesReferences
- ↑ Elmros T, Hörstedt P, Winblad B. Scanning electron microscopic study of virulent and avirulent colonies of Neisseria gonorrhoeae. Infect Immun. 1975 Sep;12(3):630-7. PMID:809360 doi:10.1128/iai.12.3.630-637.1975
- ↑ Hickie JB. Alprenolol ("aptin") in angina pectoris. A double-blind multicentre trial. Med J Aust. 1970 Aug 8;2(6):268-72 PMID:4393977